Matches in Wikidata for { <http://www.wikidata.org/entity/Q72660731> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q72660731 description "article scientifique publié en 1993" @default.
- Q72660731 description "artículu científicu espublizáu en mayu de 1993" @default.
- Q72660731 description "im Mai 1993 veröffentlichter wissenschaftlicher Artikel" @default.
- Q72660731 description "scientific article published on 01 May 1993" @default.
- Q72660731 description "wetenschappelijk artikel" @default.
- Q72660731 description "наукова стаття, опублікована в травні 1993" @default.
- Q72660731 name "Phase II evaluation of the sulfonylurea LY186,641 in men with hormone independent metastatic prostate cancer" @default.
- Q72660731 name "Phase II evaluation of the sulfonylurea LY186,641 in men with hormone independent metastatic prostate cancer" @default.
- Q72660731 type Item @default.
- Q72660731 label "Phase II evaluation of the sulfonylurea LY186,641 in men with hormone independent metastatic prostate cancer" @default.
- Q72660731 label "Phase II evaluation of the sulfonylurea LY186,641 in men with hormone independent metastatic prostate cancer" @default.
- Q72660731 prefLabel "Phase II evaluation of the sulfonylurea LY186,641 in men with hormone independent metastatic prostate cancer" @default.
- Q72660731 prefLabel "Phase II evaluation of the sulfonylurea LY186,641 in men with hormone independent metastatic prostate cancer" @default.
- Q72660731 P1433 Q72660731-784840F5-F6BB-4162-9EF4-2024AF451500 @default.
- Q72660731 P1476 Q72660731-211D7C9D-444D-4707-85A5-816FFE1F6DA0 @default.
- Q72660731 P2093 Q72660731-4ED2898D-7477-493C-9DCF-772E188D7588 @default.
- Q72660731 P2093 Q72660731-93A51577-6F1D-4A6C-80E1-5F06140BC7E7 @default.
- Q72660731 P2093 Q72660731-A35FAA15-7C6B-4EDE-AA2D-B659CB84D968 @default.
- Q72660731 P2093 Q72660731-B4D4563A-AC79-4F5F-9FD8-1774416D1301 @default.
- Q72660731 P2093 Q72660731-C71440D8-CA28-441A-B434-E933ABAF08A0 @default.
- Q72660731 P2860 Q72660731-17769783-C730-41C1-8811-EB3BC031FD0D @default.
- Q72660731 P2860 Q72660731-381BC914-E6E5-42F5-8E8B-475AE2354294 @default.
- Q72660731 P2860 Q72660731-7A698978-C697-4F8D-BA0F-714970EE9B36 @default.
- Q72660731 P2860 Q72660731-7EEEA58E-433C-4D39-80A2-DDFA6F7BF505 @default.
- Q72660731 P2860 Q72660731-AD8FA0EC-C3E1-4492-8E12-5732AF4B673F @default.
- Q72660731 P2888 Q72660731-B527EC89-0EBE-4290-80EA-8359558AC908 @default.
- Q72660731 P304 Q72660731-D9D6E2A8-3DFE-4064-B311-1EFCDFAFEAC4 @default.
- Q72660731 P31 Q72660731-3D629256-1CD2-41FB-B802-6C15304AA82B @default.
- Q72660731 P356 Q72660731-5ED69954-F813-48B6-B601-E570344AB791 @default.
- Q72660731 P433 Q72660731-AA5761B8-6503-4BA5-9643-AD40E6CCF6C5 @default.
- Q72660731 P478 Q72660731-A2E014DC-028A-4D97-8F0E-D73DADAB14E8 @default.
- Q72660731 P577 Q72660731-4EFFE7AB-E831-4524-BFE0-B7AB8510BC48 @default.
- Q72660731 P698 Q72660731-BC6921FF-7AA9-4B59-A0EF-342893237E36 @default.
- Q72660731 P356 BF00874156 @default.
- Q72660731 P698 8262732 @default.
- Q72660731 P1433 Q2312231 @default.
- Q72660731 P1476 "Phase II evaluation of the sulfonylurea LY186,641 in men with hormone independent metastatic prostate cancer" @default.
- Q72660731 P2093 "D Seitz" @default.
- Q72660731 P2093 "G Grindey" @default.
- Q72660731 P2093 "G Wilding" @default.
- Q72660731 P2093 "L Einhorn" @default.
- Q72660731 P2093 "N Munshi" @default.
- Q72660731 P2860 Q35009044 @default.
- Q72660731 P2860 Q43901766 @default.
- Q72660731 P2860 Q44736174 @default.
- Q72660731 P2860 Q46210524 @default.
- Q72660731 P2860 Q69694601 @default.
- Q72660731 P2888 bf00874156 @default.
- Q72660731 P304 "203-205" @default.
- Q72660731 P31 Q13442814 @default.
- Q72660731 P356 "10.1007/BF00874156" @default.
- Q72660731 P433 "2-3" @default.
- Q72660731 P478 "11" @default.
- Q72660731 P577 "1993-05-01T00:00:00Z" @default.
- Q72660731 P698 "8262732" @default.